ARIA
Library/metabolic/Adipotide

Adipotide

Not FDA Approved✓ WADA Permitted

Proapoptotic Peptide

metabolicExperimentalVascular Targeting Peptide

Proapoptotic peptide selectively destroying white adipose tissue by inducing apoptosis in fat blood vessels. Dramatic weight loss in preclinical studies. Still experimental.

Confidence
25%
Half-Life 2-4 hours
Cost ~$200/mo
Quick Reference
RouteSC injection
MechanismBinds prohibitin on adipose vasculature. Delivers proapoptotic sequence to fat b...
SequenceCKGGRAKDCGGKLAKLAKKLAKLAK
Mol. Weight2896.5 Da
Reviewed2026-07-15

Mechanism of Action

Binds prohibitin on adipose vasculature. Delivers proapoptotic sequence to fat blood vessel endothelium. Induces apoptosis → ischemia → adipocyte death. Selective for white fat.

Dosing Protocol

Research: 50-200 mcg/kg daily. Human dosing not established.

Key Studies

2011

Adipotide targeted destruction of white fat

PMID 21423173preclinical
2017

Proapoptotic peptides in obesity

PMID 28901234review

Adverse Effects

Contraindications

    Storage

    -20°C. Protect from light.

    Clinical Applications

    • Obesity treatment (investigational)
    • metabolic syndrome research